Waning immunity against streptococcus pneumoniae, pertussis, and tetanus in children treated for acute lymphoblastic leukemia: a canadian immunization research network study
ESPID Education. Top K. May 9, 2019; 263134 Disclosure(s): This study was received in-kind research support from Pfizer. KAT has received grants from GSK and consultancy fees from Pfizer unrelated to this work.
Dr. Karina Top
Dr. Karina Top
Only ESPID Members have access to the ESPID 2019 content. To become a member click here
Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies